Lixte Biotechnology logo

Lixte Biotechnology Share Price (NASDAQ: LIXT)

$4.4

0.48

(12.24%)

Last updated on

Check the interactive Lixte Biotechnology Stock chart to analyse performance

Lixte Biotechnology stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$3.99
    Today's High:$4.57

    Day's Volatility :12.69%

  • 52 Weeks Low:$0.64
    52 Weeks High:$5.14

    52 Weeks Volatility :87.55%

Lixte Biotechnology Stock Returns

PeriodLixte Biotechnology Holdings IncIndex (Russel 2000)
3 Months
211.7%
0.0%
6 Months
263.22%
0.0%
1 Year
140.16%
0.0%
3 Years
-46.4%
-4.7%

Lixte Biotechnology Holdings Inc Key Stats

Check Lixte Biotechnology key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$3.92
Open
$4.0
Today's High
$4.57
Today's Low
$3.99
Market Capitalization
$20.3M
Today's Volume
$218.8K
52 Week High
$5.14
52 Week Low
$0.64
Revenue TTM
$0.0
Earnings Per Share (EPS)
$-1.45
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-213.21%

Stock Returns calculator for Lixte Biotechnology Stock including INR - Dollar returns

The Lixte Biotechnology stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Lixte Biotechnology investment value today

Current value as on today

₹2,52,475

Returns

₹1,52,475

(+152.48%)

Returns from Lixte Biotechnology Stock

₹1,47,191 (+147.19%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Lixte Biotechnology Stock

-80%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Lixte Biotechnology Stock from India on INDmoney has decreased by -80% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Lixte Biotechnology Holdings Inc

  • Name

    Holdings %

  • FNY Investment Advisers, LLC

    3.53%

  • HighTower Advisors, LLC

    3.28%

  • Ethos Financial Group LLC

    0.82%

  • Citadel Advisors Llc

    0.81%

  • Geode Capital Management, LLC

    0.76%

  • Atlas Legacy Advisors, LLC

    0.45%

Analyst Recommendation on Lixte Biotechnology Stock

Rating
Trend

Lixte Biotechnology Stock Insights

  • Price Movement

    In the last 3 months, LIXT stock has moved up by 275.6%
  • LIXT vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 152.7%

Lixte Biotechnology Technicals Summary

Sell

Neutral

Buy

Lixte Biotechnology is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Lixte Biotechnology Holdings Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Lixte Biotechnology Holdings Inc logo
10.71%
263.22%
140.16%
-46.4%
-88.25%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Lixte Biotechnology Holdings Inc

Lixte Biotechnology Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on identifying targets for cancer drug development, and developing and commercializing cancer therapies. Its lead product candidate, LB-100 is in phase 1b clinical trials combined with Atezolizumab for patients with microsatellite stable metastatic colorectal cancer. The company's LB-100 combined with doxorubicin in advanced soft tissue sarcoma is under Phase 1b portion; and LB-100 combined with dostarlimab that is in phase 1b/2 for ovarian clear cell carcinoma. The company has a clinical trial research agreement with the Netherlands Cancer Institute; collaboration agreement for an investigator-initiated clinical trial with the Spanish Sarcoma Group; and a development collaboration agreement with the Netherlands Cancer Institute. Lixte Biotechnology Holdings, Inc. was founded in 2005 and is based in Pasadena, California.
Organization
Lixte Biotechnology
Employees
2
CEO
Mr. Geordan G. Pursglove
Industry
Biotechnology

Key Management of Lixte Biotechnology Holdings Inc

NameTitle
Mr. Bastiaan van der Baan M.Sc.
President, Chief Scientific Officer & Director
Mr. Robert Neal Weingarten
CFO, VP & Secretary
Mr. Geordan G. Pursglove
CEO & Chairman

Important FAQs about investing in LIXT Stock from India :

What is Lixte Biotechnology share price today?

Lixte Biotechnology share price today is $4.40 as on at the close of the market. Lixte Biotechnology share today touched a day high of $4.57 and a low of $3.99.

What is the 52 week high and 52 week low for Lixte Biotechnology share?

Lixte Biotechnology share touched a 52 week high of $5.14 and a 52 week low of $0.64. Lixte Biotechnology stock price today i.e. is closed at $4.40, lower by 14.4% versus the 52 week high.

How to invest in Lixte Biotechnology Stock (LIXT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Lixte Biotechnology on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Lixte Biotechnology Shares that will get you 0.3409 shares as per Lixte Biotechnology share price of $4.40 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Lixte Biotechnology Stock (LIXT) from India?

Indian investors can start investing in Lixte Biotechnology (LIXT) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Lixte Biotechnology stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Lixte Biotechnology share’s latest price of $4.40 as on August 30, 2025 at 1:29 am IST, you will get 2.2727 shares of Lixte Biotechnology. Learn more about fractional shares .

What are the returns that Lixte Biotechnology has given to Indian investors in the last 5 years?

Lixte Biotechnology stock has given -88.25% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?